Viewing nowCombinationAmozasartan XQ Tablet 5/50/2.5/10 mg
Losartan Potassium 50mg · Ezetimibe 10mg +2 more
Tablet · Prescription medication · Combination
Hanmi Pharmaceutical Co., Ltd.

MFDS item code 202502506 · Approved 2025.09.22 · Insurance code 643509020
Treatment of hypertension and dyslipidemia
This medication is used for patients who need to treat both hypertension and dyslipidemia. For hypertension, it is used when blood pressure treatment is difficult with monotherapy of amlodipine or losartan, or as initial treatment with a combination agent is required for stage 2 hypertension patients to reach treatment goals. In the treatment of dyslipidemia, it is given in conjunction with diet therapy to lower total cholesterol, LDL cholesterol, Apo B protein, and triglyceride levels, and to increase HDL cholesterol levels in patients with primary hypercholesterolemia or mixed dyslipidemia. Before treatment, secondary causes, such as diabetes and hypothyroidism, should be confirmed, and it is used when diet and non-drug measures are insufficient. This medication effectively controls blood pressure and lipid levels to help reduce the risk of cardiovascular diseases.
This drug is for adults only. The dose should be individualized for each patient based on the efficacy and tolerability of the amlodipine/losartan combination and the rosuvastatin/ezetimibe combination. The recommended dose of this drug is 1 tablet once daily, taken with water, with or without food. It is recommended to take it at the same time each day, if possible (e.g., in the morning). Take this drug whole; do not chew, divide, or crush it. ○ Amlodipine/losartan combination The recommended dose of the amlodipine/losartan combination is 1 tablet once daily, taken with water, with or without food. It is recommended to take it at the same time each day, if possible (e.g., in the morning). It is recommended to adjust the dose using the individual components (amlodipine or losartan) before administering the amlodipine/losartan combination. However, direct switching to the amlodipine/losartan combination may be considered when blood pressure is not controlled with monotherapy using the individual components, as follows: - 5/50 mg: Administer to patients whose blood pressure is not adequately controlled with amlodipine 5 mg or losartan 50 mg monotherapy. - 5/100 mg: Administer to patients whose blood pressure is not adequately controlled with amlodipine 5 mg or losartan 100 mg monotherapy. Before administering the amlodipine/losartan combination as initial therapy to patients with stage 2 hypertension, the decision to administer it should take into consideration baseline blood pressure, target blood pressure, and the expected likelihood of achieving the treatment target with the combination compared with monotherapy. The usual dose of the amlodipine/losartan combination is 5/50 mg once daily. If blood pressure is not adequately controlled after 2 weeks of treatment, the dose may be increased to 10/50 mg once daily. ∘ Patients with renal impairment: No dose adjustment is required in patients with mild renal impairment; however, use of the amlodipine/losartan combination is not recommended in patients with moderate renal impairment. ∘ Patients with reduced intravascular volume: Use of the amlodipine/losartan combination is not recommended in a small number of patients with reduced intravascular volume (e.g., patients receiving high doses of diuretics). (See section 1, Warnings, under Precautions for Use.) ∘ Patients with hepatic impairment: Use of the amlodipine/losartan combination is not recommended in patients with a history of hepatic impairment who require a reduced dose of losartan (e.g., 25 mg once daily). ∘ Elderly patients: In elderly patients 75 years of age or older, an initial dose of losartan of 25 mg once daily is recommended; therefore, use of the amlodipine/losartan combination as initial therapy is not recommended. ○ Rosuvastatin/ezetimibe combination Administer the rosuvastatin/ezetimibe combination once daily, with or without food. Patients should continue to follow a standard cholesterol-lowering diet before and during treatment with the rosuvastatin/ezetimibe combination. The dose of the rosuvastatin/ezetimibe combination should be adjusted according to the patient's baseline LDL-cholesterol level, recommended treatment target, and response. Primary hypercholesterolemia The dose range of the rosuvastatin/ezetimibe combination is 2.5/10mg∼20/10mg once daily. The recommended starting dose is 2.5/10mg or 5/10mg once daily. The dose may be adjusted for patients who require a greater reduction in LDL-cholesterol. After starting the rosuvastatin/ezetimibe combination or adjusting the dose, check blood lipid levels after an interval of at least 4 weeks and adjust the dose accordingly; the dose may be increased to a maximum of 20/10mg once daily. Patients taking the amlodipine/losartan combination together with the rosuvastatin/ezetimibe combination may switch to this drug (a combination product containing the same amounts of each active ingredient) for convenience.
This medication can cause serious harm to the fetus and newborns if administered to pregnant women; therefore, it should be discontinued immediately upon confirmation of pregnancy. Patients with reduced blood volume, such as those on diuretics, should be cautious as blood pressure may drop excessively when first using this medication. It is recommended to temporarily discontinue this medication for patients who may have severe muscle issues, such as acute infections or severe trauma. Patients allergic to any of the ingredients in this medication, or those with certain liver or kidney diseases, should not take this medication. Elderly patients, patients with very low blood pressure, or patients with elevated serum potassium levels should take special precautions when using this medication, and regular monitoring is recommended. This medication may cause muscle-related side effects such as muscle pain and weakness, so if these symptoms occur, it is important to notify a doctor immediately and undergo examination. It may affect liver function; therefore, patients with liver disease or elevated liver enzyme levels should regularly monitor their liver functions before and during treatment. Dizziness or drowsiness may occur during treatment, so caution is necessary when driving or operating machinery. There may be interactions with other medications, so it is essential to inform a doctor or pharmacist if other medications are being taken. If any unusual symptoms or discomfort arise while taking this medication, it is crucial to consult medical personnel immediately.
Craniosynostosis, anuria, hypotension, renal failure, elevated ALT, elevated AST, dermatitis, orthostatic dizziness, syncope, rhabdomyolysis, pancreatic adenocarcinoma, myalgia, pruritus, constipation, discomfort in the upper abdomen, nasopharyngitis, increased C-reactive protein, back pain, facial paralysis, headache, indigestion, hypertension, dizziness, drowsiness, migraine, drowsiness, neurodegenerative disorders, cough, fatigue, anemia, thrombocytopenia, dysgeusia, erythromelalgia, hyponatremia, increased serum creatinine, increased serum creatine phosphokinase, abnormal liver function tests, syncope, generalized pain, muscle cramps, gout, erectile dysfunction, weakness, fatigue, pain, weight gain, weight loss, hypotension, vasculitis, tension increase, numbness, paresthesia, peripheral neuropathy, syncope, dysgeusia, tremor, erectile dysfunction, gynecomastia, change in bowel habits, dry mouth, indigestion, gastritis, gingival hypertrophy, pancreatitis, vomiting, hyperglycemia, arthralgia, low back pain, muscle cramps, myalgia, leukopenia, thrombocytopenia, insomnia, mood changes, cough, dyspnea, rhinitis, hair loss, increased sweating, purpura, skin discoloration, urticaria, toxic epidermal necrolysis, tinnitus, visual disturbances, increased urinary frequency, urinary dysfunction, nocturia, hepatitis, jaundice, elevation of liver enzyme levels, erythema multiforme, maculopapular rash, myocardial infarction, arrhythmia, chest pain, hypotension, sinus block, atrioventricular block, abdominal discomfort, precordial pain, diarrhea, loose stools, constipation, erythema multiforme, maculopapular rash, dizziness, heat sensations, impaired glucose tolerance, weakness, lip swelling, eyelid swelling, facial rash, angioedema, vasculitis, anaphylaxis-like syndrome, liver dysfunction, hepatitis, intestinal vascular edema, fatigue, anemia, myalgia, weakness, elevated creatine kinase, increased serum myoglobin, dysgeusia, dry cough, erythromelalgia, hyperkalemia, hypoglycemia, headache, dizziness, constipation, nausea, abdominal pain, pancreatitis, arthralgia, low back pain, myalgia, facial edema, fever, orthostatic effects, syncope, angina, second-degree atrioventricular block, cerebrovascular accident, hypotension, myocardial infarction, atrial fibrillation, palpitations, bradycardia, tachycardia, ventricular tachycardia, ventricular fibrillation, loss of appetite, constipation, toothache, dry mouth, flatulence, gastritis, vomiting, anemia, gout, upper limb pain, hip joint pain, joint swelling, knee pain, musculoskeletal pain, shoulder pain, muscle rigidity, arthralgia, arthritis, fibromyalgia, myasthenia, anxiety, anxiety disorder, ataxia, confusion, depression, nightmares, sensory loss, decreased libido, memory impairment, migraine, hyperesthesia, paresthesia, peripheral neuropathy, panic disorder, sleep disorders, drowsiness, tremors, dizziness, dyspnea, bronchitis, oropharyngeal discomfort, epistaxis, rhinitis, pulmonary congestion, chest discomfort, hair loss, dermatitis, dry skin, petechial hemorrhage, erythema, flushing, photosensitivity reactions, pruritus, rash, sweating, urticaria, blurred vision, burning sensation and pain in eyes, conjunctivitis, dysgeusia, tinnitus, vision loss, erectile dysfunction, nocturia, frequent urination, urinary tract infection, angioedema, urticaria, rash, erythema multiforme, arthralgia, myalgia, elevated creatine phosphokinase levels, myopathy, rhabdomyolysis, elevated liver amino transferase levels, hepatitis, abdominal pain, thrombocytopenia, nausea, pancreatitis, paresthesia, depression, headache, cholelithiasis, cholecystitis, cold sweats, burning sensation of the skin, skin disorders, alopecia, oropharyngeal pain, nasal obstruction, respiratory distress, pelvic pain, breast cysts, ptosis, diabetic retinopathy, ear discomfort, renal impairment, benign esophageal neoplasm, angioedema, immune-mediated necrotizing myopathy, proximal muscle weakness, elevated serum CK, acute hepatitis, fulminant hepatitis, ventricular extrasystole, atrial fibrillation, hypoglycemia, weakness, hunger, cold sweats, tremors, decreased concentration, seizures, altered consciousness, polyneuropathy, amnesia, peripheral neuropathy, myasthenia gravis, interstitial lung disease, thrombocytopenia, Stevens-Johnson syndrome, eosinophilia, drug reaction with eosinophilia and systemic symptoms, drug rash resembling psoriasis, lupus-like syndrome, muscle rupture, immune-mediated necrotizing myopathy, hematuria, edema, headache, chest pain, chest discomfort, edema, weakness, generalized edema, tremor, upper abdominal pain, vomiting, epigastric discomfort, belching, gastrointestinal disorders, gastroesophageal reflux disease, tongue disorders, palpitations, congestive heart failure, myocardial ischemia, flushing, sputum, runny nose
Not everyone experiences these, and they can vary from person to person.
This medication may be sensitive to air or moisture, so it should be stored in a sealed container. It is best to maintain the storage temperature between 1 degree and 30 degrees Celsius to ensure the longevity of its effectiveness.
Light green oval film-coated tablet
PTP(Al-Al) - 30 tablets/box [10 tablets/PTP×3]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationLosartan Potassium 50mg · Ezetimibe 10mg +2 more
Tablet · Prescription medication · Combination
Hanmi Pharmaceutical Co., Ltd.
CombinationLosartan Potassium 50mg · Ezetimibe 10mg +2 more
Tablet · Prescription medication · Combination
Hanmi Pharmaceutical Co., Ltd.
CombinationLosartan Potassium 50mg · Ezetimibe 10mg +2 more
Tablet · Prescription medication · Combination
Hanmi Pharmaceutical Co., Ltd.
CombinationLosartan Potassium 50mg · Ezetimibe 10mg +2 more
Tablet · Prescription medication · Combination
Hanmi Pharmaceutical Co., Ltd.
CombinationLosartan Potassium 100mg · Ezetimibe 10mg +2 more
Tablet · Prescription medication · Combination
Hanmi Pharmaceutical Co., Ltd.
CombinationLosartan Potassium 100mg · Ezetimibe 10mg +2 more
Tablet · Prescription medication · Combination
Hanmi Pharmaceutical Co., Ltd.
CombinationLosartan Potassium 100mg · Ezetimibe 10mg +2 more
Tablet · Prescription medication · Combination
Hanmi Pharmaceutical Co., Ltd.
CombinationLosartan Potassium 100mg · Ezetimibe 10mg +2 more
Tablet · Prescription medication · Combination
Hanmi Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.